What are the early warning signs of Liddle syndrome that should prompt a doctor’s visit?

If you notice consistently high blood pressure before age 20, muscle cramps, or fainting spells, especially if you also have low potassium levels, it’s time to see a clinician. Early evaluation can catch hypertension and hypokalemia before they lead to heart complications. How is Liddle syndrome confirmed in the lab?::A blood test will show low potassium and normal or low aldosterone levels despite high blood pressure. Genetic testing for SCNN1G mutations is the definitive diagnostic step and can be done via a simple blood draw. What first‑line medications are used to treat Liddle syndrome, and why are they chosen?::Eplerenone or spironolactone, potassium‑sparing diuretics, are preferred because they block the overactive sodium channels and help restore potassium balance, unlike typical diuretics that worsen hypokalemia. Can lifestyle changes reduce the severity of Liddle syndrome symptoms?::Yes—reducing dietary sodium, staying hydrated, and avoiding high‑potassium‑blocking drugs (like certain NSAIDs) can help control blood pressure and maintain potassium levels. Regular monitoring by a healthcare provider is essential.

SCNN1G gene

The SCNN1G gene provides instructions for creating the gamma subunit of the epithelial sodium channel (ENaC), which is essential for regulating sodium and fluid balance in the body.

Normal Function

The SCNN1G gene provides instructions for making one piece, the gamma subunit, of a protein complex called the epithelial sodium channel (ENaC). The channel is composed of alpha, beta, and gamma subunits, each of which is produced from a different gene. These channels are found at the surface of certain cells called epithelial cells in many tissues of the body, including the kidneys, lungs, and sweat glands. The ENaC channel transports sodium into cells.

In the kidney, ENaC channels open in response to signals that sodium levels in the blood are too low, which allows sodium to flow into cells. From the kidney cells, this sodium is returned to the bloodstream (a process called reabsorption) rather than being removed from the body in urine. In addition to regulating the amount of sodium in the body, the flow of sodium ions helps control the movement of water in tissues. For example, ENaC channels in lung cells help regulate the amount of fluid in the lungs.

Health Conditions Related to Genetic Changes

Liddle syndrome

At least 5 mutations in the SCNN1G gene can cause a condition known as Liddle syndrome. People with Liddle syndrome have high blood pressure (hypertension) and low levels of potassium in their blood (hypokalemia), often beginning in childhood.

Mutations lead to the production of an abnormally short gamma subunit protein.
These changes affect a region involved in signaling for the protein's breakdown (degradation).
Because the protein is not degraded, more ENaC channels remain at the cell surface.
The increase in channels allows for the reabsorption of excess sodium and water, leading to hypertension and hypokalemia.

Pseudohypoaldosteronism type 1

Mutations in the SCNN1G gene are involved in pseudohypoaldosteronism type 1 (PHA1), a condition typically beginning in infancy. It is characterized by low levels of sodium (hyponatremia), high levels of potassium (hyperkalemia), and severe dehydration due to the loss of excess sodium and fluid in urine.

SCNN1G mutations are specifically involved in autosomal recessive PHA1, a severe form that does not improve with age.
Most mutations lead to an abnormally short gamma subunit protein, resulting in reduced or absent ENaC channel activity.
Impaired sodium reabsorption leads to hyponatremia.
Reduced function of ENaC channels in lung epithelial cells leads to excess fluid in the lungs and recurrent lung infections.

Other disorders

Some people with cystic fibrosis-like syndrome (also known as atypical cystic fibrosis or bronchiectasis with or without elevated sweat chloride type 3) have a mutation or a normal gene variation (polymorphism) in the SCNN1G gene. These individuals exhibit breathing problems and lung infections similar to cystic fibrosis, even when changes in the CFTR gene are not present. It is thought that these SCNN1G variations disrupt sodium transport and fluid balance.

Other Names for This Gene

amiloride-sensitive epithelial sodium channel gamma subunit
amiloride-sensitive sodium channel gamma-subunit
amiloride-sensitive sodium channel subunit gamma
BESC3
ENaC gamma subunit
ENaCg
ENaCgamma
epithelial Na(+) channel subunit gamma
gamma-ENaC
gamma-NaCH
nonvoltage-gated sodium channel 1 subunit gamma
SCNEG
SCNNG_HUMAN
sodium channel, non voltage gated 1 gamma subunit
sodium channel, non-voltage-gated 1, gamma subunit
sodium channel, nonvoltage-gated 1, gamma